1. Home
  2. DYAI vs JMM Comparison

DYAI vs JMM Comparison

Compare DYAI & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • JMM
  • Stock Information
  • Founded
  • DYAI 1979
  • JMM 1988
  • Country
  • DYAI United States
  • JMM United States
  • Employees
  • DYAI N/A
  • JMM N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • JMM Trusts Except Educational Religious and Charitable
  • Sector
  • DYAI Health Care
  • JMM Finance
  • Exchange
  • DYAI Nasdaq
  • JMM Nasdaq
  • Market Cap
  • DYAI 35.5M
  • JMM 57.2M
  • IPO Year
  • DYAI 2004
  • JMM N/A
  • Fundamental
  • Price
  • DYAI $1.07
  • JMM $6.12
  • Analyst Decision
  • DYAI Strong Buy
  • JMM
  • Analyst Count
  • DYAI 1
  • JMM 0
  • Target Price
  • DYAI $6.00
  • JMM N/A
  • AVG Volume (30 Days)
  • DYAI 35.9K
  • JMM 16.1K
  • Earning Date
  • DYAI 05-14-2025
  • JMM 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • JMM 5.44%
  • EPS Growth
  • DYAI N/A
  • JMM N/A
  • EPS
  • DYAI N/A
  • JMM N/A
  • Revenue
  • DYAI $3,495,389.00
  • JMM N/A
  • Revenue This Year
  • DYAI $117.40
  • JMM N/A
  • Revenue Next Year
  • DYAI N/A
  • JMM N/A
  • P/E Ratio
  • DYAI N/A
  • JMM N/A
  • Revenue Growth
  • DYAI 20.58
  • JMM N/A
  • 52 Week Low
  • DYAI $0.93
  • JMM $5.29
  • 52 Week High
  • DYAI $2.67
  • JMM $6.10
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 28.15
  • JMM 54.56
  • Support Level
  • DYAI $1.05
  • JMM $5.97
  • Resistance Level
  • DYAI $1.21
  • JMM $6.16
  • Average True Range (ATR)
  • DYAI 0.07
  • JMM 0.09
  • MACD
  • DYAI -0.01
  • JMM 0.02
  • Stochastic Oscillator
  • DYAI 8.33
  • JMM 85.19

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

Share on Social Networks: